รศ.(พิเศษ) พญ.ชนม์นิภา นันทวิทยา
ประวัติ
- พ.ศ. 2548- 2554: แพทยศาสตร์บัณฑิต (เกียรตินิยมอันดับสอง)จุฬาลงกรณ์ มหาวิทยาลัย
- พ.ศ. 2555-2558: ประกาศนียบัตรชั้นสูง สาขารังสีวิทยา จุฬาลงกรณ์ มหาวิทยาลัย
- พ.ศ. 2555- 2558: วุฒิบัตรแสดงความรู้คึวามชำนาญในการประกอบวิชาชีพเวชกรรม สาขารังสีรักษา
- พ.ศ. 2554-2555: แพทย์เพิ่มพูนทักษะ รพ. สมเด็จพระบรมราชเทวี ณ ศรีราชา สภากาชาดไทย
- พ.ศ. 2555-2558: แพทย์ประจำบ้าน สาขารังสีรักษาและมะเร็งวิทยา โรงพยาบาลจุฬาลงกรณ์
- ปัจจุบัน: แพทย์รังสีรักษาและมะเร็งวิทยา โรงพยาบาลจุฬาลงกรณ์
- 2015-Present: Radiation oncologist of Division of Therapeutic Radiation and Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital (KCMH)
- 2017-2018: Visiting Scientist, University of Texas MD Anderson Cancer Center, Houston, US
- 2016: Observership Program, Massachusetts General Hospital, Boston, US
- 2016: Certificate of Short course in Health Science Research, Faculty of Medicine, Chulalongkorn University
- 2015: Certificate of Verification of Standard Course in Clinical Trial and GCP Training Programme 2015, Faculty of Medicine, Chulalongkorn University
- 2015: Thai Board of Radiation Oncology
- 2015: Higher Graduate Diploma of Clinical SciencesProgram in Radiation Oncology, Chulalongkorn University, Bangkok, Thailand -GPAX 3.88
- 2014: Observership Program, National Cancer Centre Singapore, Singapore
- 2012-2015: Residency training program of Division of Therapeutic Radiation and Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital (KCMH)
- 2011-2012: Internist, Queen Savang Vadhana Memorial Hospital, the Thai Red Cross Society, Thailand
- 2005- 2011: Doctor of Medicine (MD), Chulalongkorn University, Bangkok, Thailand–2nd class Honours
- 2002 – 2005: Triam Udom Suksa School, Bangkok, Thailand
Dosimetric study of 3-dimensional conformal radiotherapy, electronic compensator technique, intensity modulated radiation therapy, and volumetric arc therapy in whole-breast irradiation.
– Nantavithya C, Saksornchai K, Oonsiri P, Shotelersuk K. Dosimetric study of three-dimensional conformal radiotherapy, electronic compensator technique, intensity-modulated radiation therapy and volumetric- modulated arc therapy in whole breast irradiation. Journal of Radiotherapy in Practice. Cambridge University Press; 2017;16(4):431–43.
– Accepted for poster presentation at the 2015 Breast Cancer Symposium, San Francisco, USA
Treatment of Medulloblastoma in Children
– Nantavithya C. Journal of Thai Society of Therapeutic Radiology and Oncology Vol. 22 No.1
Proton in Early Stage Non-Small Cell Lung Cancer
– Nantavithya C. Journal of Thai Society of Therapeutic Radiology and Oncology Vol 23 No. 1
Clinical Outcomes of Stereotactic Body Radiation Therapy Using Flattening Filter Free (FFF) in Early Non–Small Cell Lung Cancers and Metastatic Lung Cancers.
– Accepted for poster presentation at the 2017 Thoracic symposium
Kitpanit S, Songthong A, Chakkabat C, Amornwichet N, Alisanant P, Nantavithya C, Lertbutsayanukul C, Shotelersuk K, Khorprasert C, Kannarunimit D. International Journal of Radiation Oncology*Biology*Physics. 98. 10.1016/j.ijrobp.2017.01.162.
Results of intraoperative radiotherapy given as a boost after breast-conserving surgery.
– Onthong K, Chakkabat C, Nantavithya C, et al. Gland Surg. 2020;9(5):1389-1395.
– Accepted for poster presentation at 2018 ESTRO
Onthong K, Saksornchai K, Chakkabat C, Nantavithya C, Shotelersuk K. (2018). Radiotherapy and Oncology. 127. S698-S699. 10.1016/S0167-8140(18)31576-7.
A Phase II Study of Stereotactic Body Radiotherapy and Stereotactic Body Proton Therapy for High-Risk Medically Inoperable Early-Stage Non-Small Cell Lung Cancer. Chonnipa Nantavithya, Daniel R. Gomez, Xiong Wei, Joe Y. Chang, et al. International Journal of Radiation Oncology*Biology*Physics. 2018 Jul 1;101(3):558-563.
A Phase II Study of Stereotactic Body Radiotherapy and Stereotactic Body Proton Therapy for High-Risk Medically Inoperable Early-Stage Non-Small Cell Lung Cancer.
– Nantavithya C, Gomez DR, Wei X, et al. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer. Int J Radiat
Oncol Biol Phys. 2018;101(3):558‐563.
Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis after Postoperative Radiotherapy for Patients with Non-Small Cell Lung Carcinoma.
– Boonyawan K, Gomez DR, Komaki R, Xu Y, Nantavithya C, Allen PK, Mohan R, Liao Z. (2018). Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma. International journal of radiation oncology, biology, physics, 101(4), 919– 926.
An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer
– Nantavithya C, Gomez DR, Chang JY, et al. An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer. Radiother Oncol. 2020;145:209‐214.
Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis
– Nantavithya C, Paulino AC, Liao K, et al. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: a Surveillance, Epidemiology, and End Results analysis. Pediatr Blood Cancer. 2020;e28373
– Accepted for Oral Presentation at the 50th Congress of the International Society of Paediatric Oncology SIPO 2018, Kyoto, Japan.
– Accepted for poster presentation at ISPNO 2018, Denver, Colorado, USA. (Risk of developing second primary tumors and survival outcomes in medulloblastoma: a surveillance, epidemiology, and end results (SEER) analysis)
– Accepted for poster viewing at the 50th Congress of the International Society of Paediatric Oncology (SIOP), Kyoto, Japan. (Risk of developing second primary tumors and survival outcomes in medulloblastoma: a surveillance, epidemiology, and end results (SEER) analysis)
A Method for Analyzing and Reporting Patterns of In-Field Recurrence after Definitive Concurrent Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.
– Accepted for Poster Viewing Q&A session at ASTRO annual meeting 2018, San Antonio, Texas, USA.
Gandhi S, Nantavithya C, Wei X, Chang JY, et al. International Journal of Radiation Oncology*Biology*Physics.
- e698-e699.
Observed-to-expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis
– Nantavithya C, Paulino AC, Liao K, et al. Observed-to-expected incidence ratios of second malignant neoplasms
after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis. Cancer.
2021 Jul 1;127(13):2368-2375.
– Accepted for Poster Viewing Q&A session at ASTRO annual meeting 2018, San Antonio, Texas, USA. Nantavithya C, Yeboa DN, Liao K, Paulino A, et al. International Journal of Radiation Oncology*Biology*Physics. 102. e467-e468. 10.1016/j.ijrobp.2018.07.1341.
Diffuse Intrinsic Pontine Glioma in Children
– Nantavithya C. Journal of Thai Society of Therapeutic Radiology and Oncology Vol 24 No. 2
Role of Radiation in Ewing Sarcoma
– Nantavithya C. Journal of Thai Society of Therapeutic Radiology and Oncology Vol 25 No 1 Supplement
Clinical outcomes of stereotactic radiotherapy using flattening-filter-free in lung cancers.
– Accepted for poster presentation at ESTRO 2019
Taweesakulvashra T, Kitpanit S, Prayongrat A, Chakkabat C, Amornwichet N, Alisanant P, Nantavithya C, Lertbutsayanukul C, Shotelersuk K, Khorprasert C, Kannarunimit D. Radiotherapy and Oncology. 133. S733- S734. 10.1016/S0167-8140(19)31759-1.
– Jaruthien T, Kitpanit S, Kannarunimit D, Nantavithya C, Prayongrat A, Alisanant P, Saksornchai K, Amornwichet N, Raiyava T, Chakkabat C, Lertbutsayanukul C, Khorprasert C, Shotelersuk K. Transl Cancer Res. 2021 Feb;10(2):571-580
The effect of deep inspiration breath-hold technique on left anterior descending coronary artery and heart dose in left breast irradiation
– Sakyanun P, Saksornchai K, Nantavithya C, Chakkabat C, Shotelersuk K. Radiat Oncol J. 2020 Sep;38:181-188.
KRAS Mutation in Pediatric Intracranial Germ Cell Tumors.
– Khaiman C, Techavichit P, Poparn H, Chiangthong K, Lauhasurayotin S, Sosothikul D, Shotelersuk K, Nantavithya C, Jakchairoongruang K, Amornfa J, Khongkhaduead E, Santisukwongchote S, Teerapakpinyo C, Shuangshot S. Asian Pac J Cancer Prev. 2022 Sep 1;23(9):3179-3185.
Dosimetric evaluation of photons versus protons in postmastectomy planning for ultra hypofractionated breast radiotherapy.
– Oonsiri P, Nantavithya C, Lertbutsayanukul C, Sarsitthithum T, Vimolnoch M, Tawonwong T, Saksornchai K. Radiat Oncol. 2022 Jan 29;17(1):20.
Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
– Lertbutsayanukul C, Pitak M, Nantavithya C. Radiat Oncol J. 2022 Jun;40(2):141-150
Relative risk of cardiac mortality and dosimetric comparison among three-dimensional radiotherapy, volume modulated arc therapy and proton beam in vertebral body-reduced-dose craniospinal irradiation
– Accepted for poster presentation at the 55th Congress of the International Society of Paediatric Oncology SIPO
2018, Ottawa, Canada.
Nantavithya C, Prayongrat A, Oonsiri S, Shotelersuk K.